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ABSTRACT
Osteoporosis, which contributes to morbidity and mortality, often coexists with cardiovascular disease, especially atherosclerosis. We
have reported recently that in vitro exposure of human T-lymphocytes to oxidized lipids induced expression of a key osteoclastogenic
cytokine, receptor activator of NF-kB ligand (RANKL). Our previous studies have shown that mice fed an atherogenic high-fat diet
developed osteopenia and that bone marrow preosteoclasts from these hyperlipidemic mice have increased osteoclastic potential.
To investigate the role of T-lymphocytes in the diet-induced bone loss, C57BL/6 mice were fed either chow or a high-fat diet, and bone
parameters and T-lymphocyte activation were assessed at 6 and 11 months. Consistent with our previous findings, peripheral
quantitative computed tomographic (pQCT) analysis showed that mice in the high-fat group had lower bone mineral content than
mice in the chow group. Furthermore, histomorphometric analysis showed decreased structural parameters in the high-fat group.
Coculture studies showed that bone marrow cells isolated from the high-fat group, which contained increased levels of activated
memory T-lymphocytes comparedwith bonemarrow cells from the chowmice, supported osteoclastic differentiation of RAW 264.7 cells.
Additionally, RANKL expression was upregulated significantly in the T-lymphocytes isolated from the bone marrow of the high-fat group.
Splenic T-lymphocytes isolated from the high-fat group also had increased expression of transcripts for the receptor for oxidized lipids
(LOX-1) as well as for inflammatory and osteoclastogenic cytokines, including RANKL, interleukin 6 (IL-6), tumor necrosis factor a (TNF-a),
IL-1b, and interferon g (IFN-g). Together these findings suggest that T-lymphocytes play a key role in the osteoclastogenesis induced by a
high-fat diet and may contribute to the bone loss associated with diet-induced osteopenia.  2010 American Society for Bone and
Mineral Research.
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The pathophysiology of osteoporosis is complex and multi-factorial, particularly with respect to the modulatory effects
of the immune system on bone homeostasis. A central
component of the interaction between the immune and skeletal
systems is the tumor necrosis factor (TNF) receptor family
molecule receptor activator of NF-kB ligand (RANKL) produced
by bone marrow stromal cells,(1) osteoblasts,(2) and activated
T-lymphocytes.(3) Indeed, activated T-lymphocytes have been
shown to directly induce osteoclast formation from monocytes
in vitro.(4) Furthermore, T-lymphocyte-deficient mice have
decreased alveolar bone loss induced by oral infection comparedReceived in original form August 18, 2009; revised form April 7, 2010; accepted M
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2460with their immunocompetent counterparts.(5) Elevated serum
levels of inflammatory cytokines such as interleukin 6 (IL-6),
TNF-a, IL-1b, and interferon g (IFN-g) have been documented
in diseases that are also associated with bone loss, including
rheumatoid arthritis (RA),(6) inflammatory bowel disease (IBD),(7)
and periodontal disease.(8)
Hyperlipidemia increases the risk of retention and modifica-
tion of low-density lipoprotein (LDL) in arterial walls, which can
undergo oxidation in macrophage-rich tissues.(9) Oxidized LDL is
immunogenic and can recruit immune cells, including mono-
cytes and T-lymphocytes, to the subendothelial layer of the
artery wall.(10,11) Indeed, T-lymphocytes have been shown to be
present at all stages of lesion development in atherosclerosis.(10)ay 27, 2010. Published online June 7, 2010.
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A more definitive demonstration of T-lymphocyte involvement
in atherosclerosis emerged from studies of severely combined
immunodeficient (SCID) mice that were crossed with apoE/
mice, where the reduction in fatty streak aorta lesions was
reversed when the mice were reconstituted with T-lympho-
cytes.(12) Additionally, immune responses to oxidized lipids
also have been documented in regional lymph nodes and
spleen.(13,14) The primary receptor for oxidized LDL, lectin-like
oxidized LDL receptor 1 (LOX-1), which has been associated with
cardiovascular disease,(15) has been identified on endothelial
cells.(16) In the Jurkat T-lymphocyte tumor line, LOX1 mRNA was
upregulated by lysophosphatidylcholine, a lipid component of
oxidized LDL.(17) However, its expression in normal T-lympho-
cytes has not been investigated.
Cardiovascular disease, especially atherosclerosis, coexists in
patients with osteoporosis.(18) We and others have reported the
accumulation of lipids within the bones of mice and blood
vessels of patients with osteoporosis.(19,20) In addition, we have
found previously that mice placed on a high-fat diet developed
not only atherosclerosis but also osteopenia.(21) We also showed
that oxidized lipids enhance osteoblastic differentiation of
bone marrow preosteoclasts.(22) Consistent with these findings,
bone marrow preosteoclasts isolated from hyperlipidemic mice
have greater osteoclastic potential than similar cells from
normolipemic mice.(20) Therefore, the high-fat diet not only
may inhibit differentiation of osteoblasts but also may promote
differentiation of osteoclasts for bone resorption.
An often neglected observation is that fully functional
T-lymphocytes migrate back and forth between blood and
bone marrow (BM).(23,24) It seems likely, therefore, that the
loosely compartmentalized space within the BM may allow
immune and bone cells to interact with and to influence each
other. Interestingly, memory CD8 T-lymphocytes isolated from
the BM are in amore activated state and aremore abundant than
similar cells in the periphery.(25) The increased proportion of
CD8 T-lymphocytes within the BM, in fact, may account for
the inverted CD4/CD8 ratio (1:2) in that tissue compared with the
2:1 ratio in the periphery.(26) Importantly, following antigenic
activation, memory, but not naive, T-lymphocytes express
RANKL, and these RANKL-expressing memory cells preferentially
reside in the bone.(27)
Inflammatory processes are known to be associated with
decreased bone mass, but the specific involvement of
T-lymphocytes in hyperlipidemia-induced bone loss has not
been adequately addressed. Since activated T-lymphocytes
produce cytokines that affect the maturation and differentiation
of osteoclasts, in this study we used an in vivo model to
investigate the contribution of T-lymphocytes to lipid-mediated
bone loss. Our results show that splenic T-lymphocytes isolated
from mice fed a high-fat diet had increased transcripts for
multiple osteoclastogenic cytokines and for the LOX-1 oxidized
lipid receptor. In addition, bone marrow from the high-fat
group contained higher proportions of activated memory
T-lymphocytes and supported osteoclast differentiation when
cocultured with RAW 264.7 cells. These findings suggest that
T-lymphocytes involved in the inflammatory response of
atherosclerosis also may be mediators of lipid-induced bone
loss and may constitute previously unrecognized commonT-CELL CONTRIBUTION TO LIPID-MEDIATED BONE LOSSdenominators in the pathogenesis of osteoporosis and athero-
sclerosis.
Materials and Methods
Mice and diets
Male C57Bl/6 mice (Jackson Laboratory, Bar Harbor, ME, USA) at 1
month of age were placed on either a standard chow diet
(National Institute of Health 31 Mouse/Rat Diet 7013 containing
6% fat; NIH, Bethesda, MD, USA) or a high-fat (atherogenic) diet
(Teklad TD90221, containing 1.25% cholesterol, 15.8% fat, and
0.5% cholate; Harland Teklad, Madison, WI, USA). In this mouse
strain, the high-fat diet causes significant hypercholesterole-
mia(28,29) and osteopenia.(21) Femur, tibia, spleen, and plasma
were collected at 6 (n¼ 10/group) and 11 (n¼ 4/group) months
of age. The experimental protocol was reviewed and approved
by the Institutional Animal Care and Use Committee of the
University of California Los Angeles. Lipid analysis was performed
by the University of California Los Angeles (UCLA) Athero-
sclerosis Research Unit core laboratory, and c-LDL was
determined using Friedwald’s formula(30):
c-LDL ¼ total cholesterolHDLðtriglycerides=5Þ
Isolation of T-lymphocytes and bone marrow cells
T-lymphocytes were isolated from the total splenocyte popula-
tion by immunomagnetic depletion using a mixture of
biotinylated mAbs to CD14, CD16, CD19, CD56, CD36, CD123,
and CD235a and subsequently labeled with antibiotin microbe-
ads (Miltenyi Biotec, Auburn, CA, USA). Purity of T-lymphocytes
(>98%) was confirmed by flow cytometry (FACS Calibur, Becton
Dickinson, Franklin Lakes, NJ, USA) using anti-CD3 antibody (BD
Pharmingen, San Diego, CA, USA). Bone marrow cells were
flushed out with a-MEM from the femurs and tibias using 18-
gauge needles and passed through a 40mM nylon mesh cell
strainer to make a single-cell suspension. For some coculture
assays, whole bone marrow cells were incubated with
biotinylated CD3eþmonoclonal antibody, labeled with antibiotin
microbeads, and loaded onto a MACS column (Miltenyi Biotec).
The flow-through (ie, bone marrow cells depleted of T-
lymphocytes) was washed with a-MEM and used immediately
in the coculture assay.
Quantitative computed tomographic scanning
Femurs and tibias were carefully cleaned of soft tissue and fixed
in 95% ethanol. Peripheral quantitative computed tomographic
(pQCT) scans were performed on the left femur and tibia from
each mouse at 6 and 11 months. Scanning was performed with a
Stratec XCT-ResearchM (NorlandMedical Systems, Fort Atkinson,
WI, USA) and associated software (Version 5.4, Stratec Medi-
zintechnik, Pforzheim, Germany), and bone mineral content
(BMC) analysis was performed as described previously.(31) Based
on image morphology, the mean of six slices located in the
midshaft of the femur and tibia was selected for data analysis.Journal of Bone and Mineral Research 2461
Micro–computed tomographic (mCT) analysis
mCT analysis was performed on the left femur and tibia from
each mouse at 11 months. A high-resolution mCT scanner
(mCT40, Scanco, Akron, OH, USA) was used.(30) mCT data were
collected at 55 kVp and 72mA at a resolution of 16mm.
Visualization, reconstruction, and volume analysis of the data
were performed using the MetaMorph1Imaging System (Uni-
versal Imaging Corporation, Downingtown, PA, USA). Bone-
specific analyses included new bone volume (BV), tissue volume
(TV), and the BV/TV ratio.
Trabecular bone histomorphometric analysis
Left femurs from each mouse at 11 months were subjected to
static histomorphometry. Bones were fixed in 95% ethanol,
dehydrated, and embedded undecalcified in methyl methacry-
late. Longitudinal sections 5mm thick were cut on a Microm
microtome (Microm, Richards-Allan Scientific, Kalamazoo, MI,
USA) and stained with toluidine blue (pH 6.4). Static parameters
of bone formation and resorption were measured in a defined
area between 181 and 725mm from the growth plate using an
OsteoMeasure morphometry system (Osteometrics, Atlanta, GA,
USA). The terminology and units used are those recommended
by the Histomorphometry Nomenclature Committee of the
American Society for Bone and Mineral Research.
Cytokine measurement
Plasma levels of RANKL, osteoprotegerin (OPG), IL-6, and IFN-g
were measured in triplicate wells by Quantikine ELISA (R&D
Systems, Minneapolis, MN, USA) in accordance with manufac-
turer’s instructions.
Quantitative real-time PCR (RT-qPCR)
Total RNA from purified splenic and bonemarrow T-lymphocytes
was extracted using the RNeasy Mini Kit (Qiagen, Valencia, CA,
USA), and RNA concentrations were determined using the
Quant-iT Ribogreen RNA Assay Kit (Molecular Probes, Eugene,
OR, USA). Template cDNAs were synthesized with the iScript
cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA) using 500 ng of
RNA. The QT-PCR assays were performed using the iQ SYBR
Green SuperMix and IQCycler (Bio-Rad). GAPDH was used as a
normalization control. The sequences of the primers were
designed with the aid of Beacon DesignerTM Software (Palo Alto,
CA, USA). Primer sequences for each gene are listed in Table 1.Table 1. Primer Sequences Used for Quantitative Real-Time Polymer
Gene Primer se
IFN-g F - CAAGTGGCATAGATGTGGAAGAAAAGA
IL1-b F - GCAGCAGCACATCAACAAGAGC R - CC
IL-6 F - CCTTCTTGGGACTGATGCTGGTG R-TGG
LOX-1 F - CCTCTACCTCAGTATGCCTCCT R - CTTT
OPG F - CCTTGCCCTGACCACTCTTATACG R-CCT
RANKL F - GCCTCCCGCTCCATGTTCC R - TGAGTG
TNF-a F - GGAACTGGCAGAAGAGGCACTC R - GA
GAPDH F - ATTGTCAGCAATGCATCCTG R-ATGGAC
Ta: annealing temperature.
2462 Journal of Bone and Mineral ResearchSamples were run in triplicate in a 96-well plate using the
settings of 958C for 15 seconds, 61 to 608C for 30 seconds, and
728C for 30 seconds (single fluorescence measurement).
Flow cytometry
Phenotypic analysis of bone marrow cells was assessed by flow
cytometry. Briefly, cells were washed twice with PBS and
resuspended in staining buffer (BD Biosciences, San Jose, CA,
USA). Cells were incubated with CD3 FITC, CD8 PE, CD4 PerCp,
CD44 APC, CD62L PE, and CD69 PerCp (BD Biosciences) for
20minutes at 48C in the dark, washed, and resuspended in 1%
paraformaldehyde. Data were acquired by BD FACS Calibur (BD
Biosciences) and analyzed with CellQuest Pro (BD Biosciences).
Osteoclast assays
The ability of bone marrow cells to support osteoclast formation
was determined by coculturing bone marrow cells (0.3 106
cells/well) with the RAW 264.7 mouse monocytic cell line (ATCC,
Manassas, VA, USA) at 0.5 103 cells/well in 96-well plates for
10 days. Cells were cultured in a-MEM supplemented with 10%
fetal bovine serum (FBS), 50 IU/mL of penicillin/streptomycin, 1%
sodium pyruvate, and 20 IU/mL of recombinant human IL-2. The
medium was replaced every 3 days. At the end of the culture
period, tartrate-resistant acid phosphatase (TRAP) staining was
performed using a commercial kit (Sigma, St Loius, MO, USA).
Multinucleated (>3 nuclei) TRAPþ cells were identified as
osteoclasts and enumerated by light microscopy.
Statistical analysis
Data in the graphs indicate the mean SD calculated from
independent experiments unless otherwise specified. The
Wilcoxon rank-sum test, a nonparametric test that is powerful
in analyzing small sample sizes,(32) was used to compare groups.
Statistical significance was defined as p .05.
Results
Effect of high-fat diet on plasma lipid levels and bone
parameters
Hyperlipidemia was induced in C57Bl/6 mice that were fed a
high-fat diet starting at 1 month of age, consistent with previous
reports.(21) The diet significantly increased total cholesterol (TC),
low-density lipoprotein (c-LDL), and unesterified cholesterol (UC)ase Chain Reaction
quence Ta
G R - AATGACGCTTATGTTGTTGCTGATGG 61
ACGGGAAAGACACAGGTAGC 61
TATCCTCTGTGAAGTCTCCTCTC 61
GCATGTTATTTCTCGGACGA 60
TCCTCACACTCACACACTCG 61
CTGTCTTCTGATATTCTGTTAG 61
ATGAGAAGAGGCTGAGACATAGGC 61
TGTGGTCATGAGCC 60
GRAHAM ET AL.
Fig. 1. Plasma lipoprotein levels and pQCT analysis of femoral tibial
bone. (A) Plasma triglycerides (TGs), total cholesterol (TC), HDL, c-LDL,
and unesterified cholesterol (UC) of chow and high-fat groups. Error bars
indicate SD. (B) Total BMC of femur was determined by pQCT. (C) Total
BMC of tibia was determined by pQCT. Data are expressed as mean SE.
ap .05; bp .01 compared to chow-fed control.
Table 2. Histomorphometric Analysis of Trabecular Bone From
Femurs of C57BI/6 Mice After 11 Months on Chow or High Fat
Diet
Chow High Fat Percent change
TV (mm) 0.63 0.02 0.58 0.04 8.8
BV (mm) 0.09 0.01 0.05 0.01b 47.2
BV/TV (%) 13.61 2.09 7.8 1.72b 42.7
Tb.Th (mm) 29.57 4.27 20.51 3.20a 30.7
Tb.Sp (mm) 196.93 26.42 256.96 24.28a þ30.5
Tb.N (/mm) 4.62 0.51 3.70 0.33a 20.0
TV: Tissue Volume; BV: Bone Volume; Tb.Th: Trabecular Thickness; Tb.
Sp: Trabecular Separation; Tb.N.: Trabecular Number Data represented as
mean SE.
ap 0.05; bp 0.01 compared to chow-fed control.in the high-fat group compared with the chow group based on
analyses of 6- and 11-month-old mice (Fig. 1A). pQCT analysis
showed that while femoral and tibial bone mineral content
(BMC) increased from 6 to 11 months in the chow group, as
expected with growing mice, BMC of mice in the high-fat group
did not increase (Figs. 1B, C). Although the body weight
increased from 6 to 11 months in both groups, there was noT-CELL CONTRIBUTION TO LIPID-MEDIATED BONE LOSSsignificant difference between the chow and high-fat groups
(data not shown). In addition, consistent with our previous
findings, the BMC values of both femur and tibia were
significantly lower in the high-fat group than in the chow
group by 9% and 21–25% at 6 and 11 months, respectively
(Fig. 1B, C). Bone mineral density (BMD) values of the femur and
tibia also showed a nonsignificant trend toward decrease in the
high-fat group at both 6 and 11 months (data not shown).
Futhermore, histomorphometric analysis of femoral bone
at 11 months showed a significant decrease in structural
parameters in the high-fat group, including trabecular bone
volume (BV/TV, 42.7%), trabecular thickness (Tb.Th, 30.7%), and
trabecular number (Tb.N, 20%) with an increase in trabecular
separation (Tb.Sp, 30.5%; Table 2).mCT analysis of left femurs and
tibias is presented in Table 3. The high-fat group had significantly
reduced bone structure in both femur and tibia, including cross-
sectional tissue area (T.Ar), cross-sectional tissue perimeter
(T.Pm), and cross-sectional bone area (B.Ar). Tibial bone from
the high-fat group also had significantly lower cross-sectional
bone perimeter (B.Pm), cross-sectional thickness (Cs.Th), cortical
thickness, and cortical bone area (B.Ar/T.Ar, 8.6%) and the
femoral bone showing similar decreases with a trend toward
significance (Table 3).
Effect of high-fat diet on splenic T-lymphocyte expression
of inflammatory and osteoclastogenic cytokines
Hyperlipidemia has been documented extensively to cause a
chronic inflammatory state by inducing the production of
inflammatory cytokines,(33–35) including the cytokines known
to induce bone resorption.(36,37) To determine the potential
contribution of T-lymphocytes, one possible source of many of
these inflammatory cytokines, we isolated splenic T-lymphocytes
from both groups of mice and tested the message expression
immediately ex vivo using RT-qPCR. Our analysis showed that the
T-lymphocytes from the high-fat group had increased transcript
levels for IL-6, TNF-a, IL-1b, IFN-g, and RANKL and a decrease in
OPG transcript expression (Fig. 2A–F). After measuring lipid levels
in the plasma, we used the remaining plasma to evaluate
circulating levels of several key osteoclastogenic cytokines.
Consistent with the increased T-lymphocyte message levels, the
plasma contained a corresponding increase in both IL-6 andJournal of Bone and Mineral Research 2463
Table 3. MicroCT Analysis of Femoral and Tibial Bones From C57BI/6 Mice After 11 Months on Chow or High Fat Diet
Femur Tiba
Chow High Fat % change Chow High Fat % change
T.Ar (mm2) 2.207 0.012 1.954 0.060b 11.5 1.340 0.012 1.139 0.042b 15.1
T.Pm (mm) 5.801 0.027 5.482 0.089a 5.5 4.562 0.037 4.194 0.078b 8.1
B.Ar (mm2) 0.877 0.054 0.700 0.033a 20.3 0.686 0.028 0.532 0.022b 22.4
B.Pm (mm) 10.425 0.056 10.002 0.167y 4.1 7.866 0.076 7.254 0.130b 7.8
Cs.Th (mm) 0.169 0.011 0.140 0.006z 17.1 0.174 0.008 0.147 0.004a 16.0
Cortical Th (mm) 0.021 0.000 0.020 0.000 2.4 0.021 0.000 0.020 0.000a 2.2
B.Ar/T.Ar (%) 0.398 0.025 0.358 0.011 10.1 0.511 0.018 0.467 0.003a 8.6
T.Ar: cross sectional Tissue Area; T.Pm: cross sectional Tissue Perimeter; B.Ar: cross sectional Bone Area; B.Pm: cross sectional Bone Perimeter; Cs.Th: Cross
sectional Thickness Data represented as mean SE.
ap 0.05; bp 0.01; yp¼ 0.054; zp¼ 0.06 compared to chow-fed control.RANKL proteins in the high-fat group at both 6 and 11 months
(Fig. 2G, H). Circulating levels of IFN-g also were increased at
6 months (data not shown) but, owing to the limited amount of
plasma, could not be evaluated at 11 months. Interestingly, inFig. 2. Message levels of inflammatory cytokines and osteogenic soluble facto
expression of (A) IL-6, (B) TNF-a, (C) IL-1b, (D) IFN-g, (E) RANKL, and ( F) OPG by T-
of plasma (G) IL-6, (H) RANKL, and (I) OPG protein levels from high-fat and chow
chow-fed control.
2464 Journal of Bone and Mineral Researchcontrast to the decreased OPG message in the T-lymphocytes,
serum OPG levels actually were increased by the high-fat diet,
suggesting that the circulating OPG may be derived from other
sources (Fig. 2I). Nevertheless, the RANKL/OPG ratio, a keyrs. RT-qPCR analysis of gene expression compared with GAPDH. Relative
lymphocytes from either the chow or high-fat group. ELISA measurement
groups. Data are expressed as mean SD. ap .05; bp .01 compared to
GRAHAM ET AL.
modulator of bone homeostasis, remained elevated in the high-
fat diet mice at 11 months (0.047 for the chow group and 0.094
for the high-fat group), consistent with the observed bone loss
seen in these mice.
Effect of high-fat diet on T-lymphocyte LOX-1 expression
Since LOX-1 has been identified as the primary receptor for
oxidized lipids in several non-immune cell types, we assessed its
message expression in freshly isolated splenic T-lymphocytes.
Results from RT-qPCR showed that LOX-1message was increased
in the high-fat group compared with the chow group at both 6
and 11 months (Fig. 3). This finding is consistent with our
previous findings showing that in vitro exposure to oxidized
lipids induced expression of LOX-1 in human T-lymphocytes.(38)
Effect of high-fat diet on T-lymphocyte activation in
bone marrow
Consistent with previous reports,(26) the relative proportion of
CD8 (versus CD4) T-lymphocytes was increased in the BM of all
the mice. However, the proportion of CD8 T-lymphocytes within
the BM of the high-fat group was significantly higher than that in
the chow group at both 6 and 11 months (Fig. 4A). The well-
documented increase inmemory and activated T-lymphocytes in
the BM(39,40) also was exaggerated in the high-fat group. The
representative flow cytometry dot-plot analysis (Fig. 4B) and the
composite data (Fig. 4C) show that at both 6 and 11 months the
BM of the high-fat group had a significantly higher proportion of
memory T-lymphocytes, defined as CD3þCD44hiCD62Lnull com-
pared with the chow group. Moreover, within the total memory
T-lymphocyte population, the proportion of cells that were in an
activated state (ie, CD69þ) was significantly higher in the high-fat
group (Fig. 4C).
Since BM from the high-fat group contained increased level of
activated T-lymphocytes, we sought to determine whether the
ability of BM cells to support osteoclastic differentiationmight be
enhanced. BM cells were cocultured with the murine RAW 264.7
monocytic cell line for 10 days, and TRAP staining was performed
to evaluate osteoclast numbers. The cultures were supplemen-
ted with IL-2 to ensure continued T-lymphocyte viability. OurFig. 3. LOX-1 expression by T-lymphocytes. Relative gene expression
(compared with GAPDH) of LOX-1 transcripts in splenic T-lymphocytes of
chow and high-fat groups. Data are expressed as mean SD. ap .05;
bp .01.
T-CELL CONTRIBUTION TO LIPID-MEDIATED BONE LOSSdata show that in the cocultures containing BM cells
immunomagnetically depleted of T-lymphocytes, there were
no significant difference in the number of multinucleated TRAPþ
cells (Fig. 4D). However, the cocultures containing the whole BM
(ie, with T-lymphocytes) from the high-fat group had significantly
more TRAPþ osteoclasts than those from the chow group at both
6 and 11 months (Fig. 4E). Additionally, RANKL expression was
increased in the isolated BM T-lymphocytes of the high-fat group
compared with the chow group (Fig. 4F). The RAW 264.7 cells
that were cultured in the absence of BM cells showed low but
measurable numbers of TRAPþ cells, consistent with reports
showing that IL-2 stimulates TRAP production in mouse calvarial
bone.(41) Importantly, BM cell cultures that contained no RAW
cells had a minimal number of TRAPþ cells, with a mean of fewer
than 31 TRAPþ cells for chow and high-fat groups, confirming
that the osteoclasts seen in the cocultures were derived from
RAW cells (Fig. 4E). Although it is not possible to rule out a
possible contribution of BM stromal osteoblast cells, our data
suggest that the increased activated memory T-lymphocytes in
the BM of the high-fat diet mice (Fig. 4C) may be responsible for
the increased osteoclastic differentiation.
Discussion
The role of lipid and lipoprotein oxidation in the pathophysiol-
ogy of osteoporosis has been suggested by a variety of
studies.(42,43) Consistent with our previous report, mice that were
fed an atherogenic high-fat diet not only became hyperlipidemic
but also showed significantly reduced mineral content and
BV/TV in both the femoral and tibial bones. The major new
findings of this study relate to the key role of T-lymphocyte in
hyperlipidemia-induced bone loss in these mice. Specifically, we
demonstrate that T-lymphocytes isolated from the spleen and
BM from the high-fat group showed increased expression of
RANKL message. Moreover, splenic T-lymphocytes had reduced
OPG message expression. Increased RANKL expression also was
seen at the protein level within the plasma of these mice.
Additionally, T-lymphocytes from the high-fat group expressed
transcripts for several other osteoclastogenic cytokines. Further-
more, the bone marrow of the high-fat group, which contained
increased proportions of T-lymphocytes with memory and
activation markers, supported increased osteoclastic differentia-
tion in coculture assay.
T-lymphocytes from the high-fat group, tested immediately ex
vivo, show an increase in the message levels of several cytokines
that have well-documented associations with inflammation and
bone loss, including IL-6,(44) TNF-a,(45) and IL-1b.(46) The message
levels for IFN-g also were increased, but the role of IFN-g in bone
metabolism is somewhat controversial. One murine study
showed that IFN-g directly inhibits RANKL-mediated osteoclas-
togenesis by induction of TNF receptor associated factor-6
(TRAF6) degradation.(47) However, randomized, controlled trials
have shown that IFN-g did not prevent bone loss in patients with
rheumatoid arthritis (RA).(48) Moreover, it was demonstrated
recently that although IFN-g can inhibit osteoclast formation
directly; it also promotes bone resorption indirectly via antigenic-
driven T-lymphocyte activation and subsequent secretion ofJournal of Bone and Mineral Research 2465
Fig. 4. Phenotypic and functional analysis of bone marrow cells. Bone marrow cells isolated from the femur and tibia were analyzed phenotypically by
flow cytometry and functionally based on their ability to support osteoclast maturation. (A) Mean proportion of CD44hi/CD4þ and CD44hi/CD8þ cells from
BM of chow and high-fat mice at 6 and 11months. (B) Representative flow cytometry dot plot; BM cells were first gated on T-lymphocytes (CD3þ), and then
the proportion of memory cells (CD44hi/CD62Lnull) was further analyzed for cell surface expression of the activation marker CD69. Representative dot-plot
analysis of memory and activated memory T-lymphocytes from BM of chow and high-fat fed groups at 6 and 11 months. (C) Mean proportion of memory
and activated memory T-lymphocytes in BM from chow and high-fat groups at 6 and 11 months. (D) Number of TRAPþ cells in cocultures containing T-
lymphocyte-depleted BM cells from 6-month chow and high-fat groups. Each BM population was cocultured with RAW 264.7 cells for 10 days in the
presence of 20 IU/mL of rh-IL-2. Data are expressed as mean SE. (E). BM cells from 6- and 11-month chow and high-fat groups were each cocultured with
RAW 264.7 cells for 10 days in the presence of 20 IU/mL of rh-IL-2. Graph representsmean numbers of TRAPþ cells from cultures of chow BM alone, high-fat
BM alone, RAW control, and RAW with BM cells from chow and high-fat groups. Data are expressed as mean SD. ( F) RT-qPCR analysis of RANKL
expression from T-lymphocytes isolated from BM cells from 6-month chow and high-fat groups. Data are expressed as mean SE. ap .05; bp .01.RANKL and TNF-a so that the net effect of IFN-g on bone
remodeling was bone loss. The interaction between the immune
and skeletal system is further strengthened by a recent study
that showing that an imbalance of the RANKL/OPG ratio affected2466 Journal of Bone and Mineral Researchosteoblast activity with subsequent low bone formation in the
adenosine deaminase (ADA)-deficient SCID mouse model.(49)
To our knowledge, our study provides the first demonstration
of lipid-induced increased expression of the LOX-1 in T-GRAHAM ET AL.
lymphocytes in vivo. This receptor had been identified previously
as the primary oxidized LDL receptor on endothelial cells,(16) and
its expression on macrophages can be induced by TNF-a.(50)
Interestingly, C-reactive protein (CRP), a nonspecific serum
marker of inflammation that is a strong predictor of cardiovas-
cular disease, hypertension, and diabetes(33,51) was shown
recently to interact directly with LOX-1.(52) We had found
previously that oxidized lipids induce LOX-1 expression by
human T-lymphocytes in vitro.(38) Here we show that splenic
T-lymphocytes from the high-fat group have higher LOX-1
expression, which theoretically could bind to circulating CRP,
further enhancing T-lymphocyte activation and cytokine release.
Ongoing studies in our laboratory are examining the potential
role of CRP in the oxidized lipid induction of T-lymphocyte-
mediated bone loss.
In addition to the enhanced inflammatory profile of splenic
T-lymphocytes in the high-fat mice, several notable changes
were observed in the BM as well. Indeed, other studies, not
related to osteoporosis, have suggested that the BM can function
as a secondary lymphoid organ, with mature T-lymphocytes
migrating back and forth between blood and BM.(23,24) The BM
also has been shown to play a central role in the maintenance
of memory CD8 T-lymphocytes.(25) In this regard, it is highly
relevant that the BM of the high-fat group contained significantly
greater proportions of CD8 T-lymphocytes and activated
memory T-lymphocytes and that this BM was able to support
osteoclast formation in the complete absence of exogenous
RANKL and macrophage colony-stimulating factor (M-CSF).
A role for CD8 T-lymphocytes in bone metabolism had been
documented previously in a study on postmenopausal women
that showed that the proportion of CD8 T-lymphocytes
coexpressing TNF-a and IFN-g was significantly higher in the
women with osteoporotic fractures than in the control
subjects.(53) Consistent with that human study, our own results
suggest that the BM cells from the high-fat diet micemay contain
all the necessary factors to induce osteoclastogenesis.
An additional aspect of our study that is highly relevant to the
human population is the fact that as early as 6 months of age the
high-fat mice failed to show the usual increase in BMC (Fig. 1B).
Studies aimed at elucidating the impact of body fat on bone
density have suggested that subcutaneous fat is beneficial to
peak bone mass, whereas visceral fat has negative effects on
bone in both healthy and HIVþ individuals.(54–56) Moreover, Lac
and colleagues showed that during the early growth period
(ie, 35 days), rats fed a high-fat diet had lower bone BMC
and BMD along with a negative correlation between visceral fat
and BMD.(57) These findings are relevant to human health, where
high-cholesterol diets are becoming more prevalent even in
children, and evidence suggests that hyperlipidemic youth are
more likely to be diagnosed with cardiovascular disease when
they reach adulthood.(58) Furthermore, based on our own
findings and reports by others, oxidized lipids not only can
induce osteoclastic differentiation(22) but also can inhibit the
differentiation of osteoblasts.(59) Moreover, Hirasawa and
colleagues showed that 5-week-old ApoE/ mice (the same
background strain as in this study) given a high-fat diet for
12 weeks had a greater number of osteoclasts in the trabecular
bone, as well as increased osteoclast activity in the corticalT-CELL CONTRIBUTION TO LIPID-MEDIATED BONE LOSSendosteum, compared with control mice.(60) Therefore, hyperli-
pidemia and the subsequent effects of increased oxidized lipid
levels not only may affect bone loss during aging but also may
interfere with proper bone development early in life.
Based on our findings, we propose that T-lymphocytes may be
one of the missing links in the documented lipid-mediated bone
loss. There is increasing evidence that nutritional interventions
may modulate oxidative stress, which can affect the generation
of oxidized lipids. For example, the antioxidant cocoa polyphenol
was reported to increase HDL, decrease LDL, and also decrease
the oxidant susceptibility of LDL in both human and rodents.(61)
Treatment with vitamin E has been shown to reduce inflamma-
tion-induced cytokine production in vitro not only by immune
cells(62) but also by skeletal and cardiac muscle.(63) Furthermore,
changes to diet and/or lifestyle that can decrease excess amount
of visceral fat also can be beneficial. The results of this study
suggest that these treatments may function, at least in part,
by reducing the T-lymphocyte exposure to oxidized lipids.
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